Novaremed
Phase 2Novaremed Announces Completion of All Patient Visits in NIH-Funded Phase 2b Trial of Non-Opioid Nispomeben for Treating Chronic Pain Associated with Diabetic Peripheral Neuropathy
Founded
2008
Focus
Small Molecules
About
Novaremed Announces Completion of All Patient Visits in NIH-Funded Phase 2b Trial of Non-Opioid Nispomeben for Treating Chronic Pain Associated with Diabetic Peripheral Neuropathy
Funding History
3Total raised: $60M
Series C$30MUndisclosedJun 15, 2018
Series B$20MUndisclosedJun 15, 2015
Series A$10MUndisclosedJun 15, 2012
Company Info
TypePrivate
Founded2008
LocationBasel, Switzerland
StagePhase 2
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile